Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (20)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Foresta, C.
Right arrow Articles by Ferlin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Foresta, C.
Right arrow Articles by Ferlin, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 16, No. 8, 1543-1547, August 2001
© 2001 European Society of Human Reproduction and Embryology

Debate continued

Prognostic value of Y deletion analysis

The role of current methods

Carlo Foresta1,, Enrico Moro and Alberto Ferlin

University of Padova, Department of Medical and Surgical Sciences, Clinica Medica 3, Via Ospedale 105, 35128 Padova, Italy

Y chromosome microdeletions represent the most frequent genetic alteration in azoospermic and severely oligozoospermic men, and screening for microdeletions in AZFa, b and c are routinely performed in the major andrology and infertility centres. Since patients with Y microdeletions often require intracytoplasmic sperm injection (ICSI), the question of whether the type of the microdeletion present could have prognostic value for the presence of spermatozoa in the ejaculate or in the testes [by testicular sperm extraction (TESE)] is an interesting one. The review of the literature on this topic showed that there is still no clear genotype–phenotype relationship, i.e. similar testicular alterations may be caused by different types of microdeletions, and apparently identical microdeletions may be associated with diverse tubular damage. Even in azoospermic men, the localization of the microdeletion cannot be used as a valid prognostic parameter before TESE–ICSI to identify patients with spermatozoa in their testes. The only finding with absolute negative prognostic value is the presence of complete AZFa–c deletions, which are invariably associated with an absence of spermatozoa. Microdeletions in AZFa or AZFb seem to have promising prognostic value, but more data and gene–specific deletions have to be provided to draw clear conclusions. The absence of a clear genotype–phenotype relationship, and therefore of a prognostic value of Y deletion analysis, is probably due to the current methods used for the screening of the microdeletions. In fact, to date most centres do not use gene-specific markers but instead use anonymous primers that contribute little information to the pathogenic role of the microdeletions.

Key words: azoospermia/ICSI/pathogenesis/TESE/Y chromosome deletions

1 To whom correspondence should be addressed. E-mail: forestac{at}protec.it


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Mol Hum ReprodHome page
P. Costa, R. Goncalves, C. Ferras, S. Fernandes, A. T. Fernandes, M. Sousa, and A. Barros
Identification of new breakpoints in AZFb and AZFc
Mol. Hum. Reprod., April 1, 2008; 14(4): 251 - 258.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A. Ferlin, B. Arredi, E. Speltra, C. Cazzadore, R. Selice, A. Garolla, A. Lenzi, and C. Foresta
Molecular and Clinical Characterization of Y Chromosome Microdeletions in Infertile Men: A 10-Year Experience in Italy
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 762 - 770.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
R.I. McLachlan, E. Rajpert-De Meyts, C.E. Hoei-Hansen, D.M. de Kretser, and N.E. Skakkebaek
Histological evaluation of the human testis--approaches to optimizing the clinical value of the assessment: Mini Review
Hum. Reprod., January 1, 2007; 22(1): 2 - 16.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
K. Aittomaki, U.-B. Wennerholm, C. Bergh, A. Selbing, J. Hazekamp, and K.-G. Nygren
Safety issues in assisted reproduction technology: Should ICSI patients have genetic testing before treatment? A practical proposition to help patient information
Hum. Reprod., March 1, 2004; 19(3): 472 - 476.
[Abstract] [Full Text] [PDF]

Home page
 J AndrolHome page
L. Yogev, S. Segal, E. Zeharia, R. Gamzu, B. B. Maymon, G. Paz, A. Botchan, R. Hauser, H. Yavetz, and S. E. Kleiman
Sex Chromosome Alignment at Meiosis of Azoospermic Men With Azoospermia Factor Microdeletion
J Androl, January 1, 2004; 25(1): 110 - 116.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
J. J. Kurinczuk
Safety issues in assisted reproduction technology: From theory to reality--just what are the data telling us about ICSI offspring health and future fertility and should we be concerned?
Hum. Reprod., May 1, 2003; 18(5): 925 - 931.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
A Ferlin, E Moro, A Rossi, B Dallapiccola, and C Foresta
The human Y chromosome's azoospermia factor b (AZFb) region: sequence, structure, and deletion analysis in infertile men
J. Med. Genet., January 1, 2003; 40(1): 18 - 24.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.